TFEB and Alzheimer disease: In vitro studies have identified other genes such as AChE (Garcia-Ayllon et al., 2011) and TFEB (Guo et al., 2017; Xu et al., 2020) playing roles in AD pathologies, which provides potential targets for AD therapy.